Get the latest tech news

Philips Gets Warning Letter From US FDA on Device Facilities

Philips received a letter from the US Food and Drug Administration warning the medical equipment maker that three of its device facilities in the US and the Netherlands didn’t comply with manufacturing standards.

None

Get the Android app

Or read this on Bloomberg

Related news:

First long-acting hair regrowth pill hailed as 'new benchmark' | This drug has been in the pipeline since 2021, and could soon get FDA approval for treating pattern hair loss

FDA Takes Action to Make a Treatment Available for Autism Symptoms

Philips announces digital pathology scanner with native DICOM JPEG XL output

« US, South Korea to Sign Deal Boosting AI, Quantum Cooperation

Euro cloud alliance urges action on Broadcom as Microsoft mends fences »